Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors

European Journal of Pharmacology

Volumn 562, Issue 1-2, 2007, Pages 111-118

  Deschaseaux, Frédéric ^a   Selmani, Zohair ^a   Falcoz, Pierre Emmanuel ^b   Mersin, Nursen ^b   Meneveau, Nicolas ^b   Penfornis, Alfred ^b   Kleinclauss, Colette ^b   Chocron, Sidney ^b   Etievent, Joseph Philippe ^b   Tiberghien, Pierre ^a   Kantelip, Jean Pierre ^b   Davani, Siamak ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b Bâtiment Socrate   (France)

Author keywords

Characterization; Endothelial progenitor cell; Progenitor marker; Statins

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD31 ANTIGEN; CD34 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LONG TERM CARE; MALE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

AGED; ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, CD31; ANTIGENS, CD34; CADHERINS; CELL COUNT; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CORONARY DISEASE; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33947502343     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.045     Document Type: Article

References (23)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Chan J.Y., and Watt S.M. Adhesion receptors on haematopoietic progenitor cells. Br. J. Haematol. 112 (2001) 541-557
3. Chavakis E., Aicher A., Heeschen C., Sasaki K., Kaiser R., El Makhfi N., Urbich C., Peters T., Scharffetter-Kochanek K., Zeiher A.M., Chavakis T., and Dimmeler S. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med. 201 (2005) 63-72
4. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., and Coukos G. Vascular leukocytes contribute to tumor vascularization. Blood 105 (2005) 679-681
5. Davani S., Deschaseaux F., Chalmers D., Tiberghien P., and Kantelip J.P. Can stem cells mend a broken heart?. Cardiovasc. Res. 65 (2005) 305-316
6. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., and Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108 (2001) 391-397
7. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., and Simari R.D. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93 (2003) 1023-1025
8. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003) 593-600
9. Hristov, M., Fach, C., Becker, C., Heussen, N., Liehn, E.A., Blindt, R., Hanrath, P., Weber, C., in press. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis.
10. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., and Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 288-293
11. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., and Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
12. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., Kim Y.J., Soo Lee D., Sohn D.W., Han K.S., Oh B.H., Lee M.M., and Park Y.B. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
13. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., Sessa W.C., and Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6 (2000) 1004-1010
14. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105 (2000) 71-77
15. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., De Ferrari G.M., Ferlini M., Goffredo L., Bertoletti A., Klersy C., Pecci A., Moratti R., and Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
16. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
17. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
18. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
19. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., and Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
20. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K., Shimada T., Oike Y., and Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
21. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., and Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
22. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-E7
23. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D.W., Asahara T., and Isner J.M. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024